Guardant Health is a biotechnology company that develops precision diagnostic tests, mainly for cancer. Its lobbying focuses on improving access to cancer screening and supporting innovation in precision diagnostics, cancer care, and preventive screening. The filings show $240,000 reported across four filings and work done with Todd Strategy Group.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
DANIEL M TODD
The latest disclosures for this client.
TODD STRATEGY GROUP
Q1TODD STRATEGY GROUP
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
TODD STRATEGY GROUP
NICHOLAS UEHLECKE
TODD STRATEGY GROUP
PAUL EDATTEL
TODD STRATEGY GROUP
TODD STRATEGY GROUP
Q3TODD STRATEGY GROUP
Q2TODD STRATEGY GROUP
RR